Page 4 - James Paul Scopa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James paul scopa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Paul Scopa Today - Breaking & Trending Today

DICE Therapeutics (NASDAQ:DICE) Shares Down 5.3%

DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating)’s stock price traded down 5.3% during mid-day trading on Thursday . The stock traded as low as $27.79 and last traded at $27.79. 267,105 shares traded hands during mid-day trading, a decline of 44% from the average session volume of 473,216 shares. The stock had previously closed at […] ....

James Paul Scopa , Metlife Investment Management , Securities Exchange Commission , York Mellon Corp , Therapeutics Inc , Jpmorgan Chase Co , Dice Therapeutics Inc , Blackrock Inc , Get Rating , Trading Down , Director James Paul Scopa , Exchange Commission , Director Ra Capital Management , New York Mellon Corp , Life Investment Management , Dice Therapeutics , Nasdaq Dice ,

Insider Selling: DICE Therapeutics, Inc. (NASDAQ:DICE) Director Sells $290,500.00 in Stock

DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) Director James Paul Scopa sold 10,000 shares of DICE Therapeutics stock in a transaction dated Friday, March 17th. The shares were sold at an average price of $29.05, for a total transaction of $290,500.00. Following the transaction, the director now owns 23,719 shares of the company’s stock, valued […] ....

James Paul Scopa , Jpmorgan Chase Co , Metlife Investment Management , Therapeutics Inc , Blackrock Inc , Securities Exchange Commission , Dice Therapeutics Inc , York Mellon Corp , Get Rating , Director James Paul Scopa , Exchange Commission , New York Mellon Corp , Life Investment Management , Dice Therapeutics , Nasdaq Dice , Insider Trading , Nsider Trades ,